Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 8.1 | 13.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.2 |
| Revenue growth | -40.6% | | | | | | -100.0% | |
| Cost of goods sold | 1.5 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.6 |
| Gross profit | 6.6 | 12.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.4 |
| Gross margin | 81.8% | 94.3% | | | | | | -56.6% |
| Selling, general and administrative | 114.5 | 85.9 | 88.4 | | | | | |
| Research and development | | | | 94.7 | 58.0 | 39.9 | 20.1 | |
| General and administrative | | | | 24.6 | 17.7 | 15.0 | 5.5 | 2.4 |
| EBIT | -107.9 | -73.0 | 0.0 | -119.3 | -75.7 | -54.9 | -25.6 | -6.6 |
| EBIT margin | -1333.4% | -536.2% | | | | | | -156.6% |
| Pre-tax income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -53.2 | -23.8 | -6.7 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.1 | -2.2 | 0.0 |
| Tax rate | | | | | | 2.0% | 9.4% | 0.0% |
| Net income | 0.0 | 0.0 | 0.0 | -117.2 | -74.8 | -39.3 | -17.2 | -6.7 |
| Net margin | 0.0% | 0.0% | | | | | | -159.0% |
| |
| Diluted EPS | $0.00 | $0.00 | $0.00 | ($2.91) | ($2.25) | ($2.88) | ($10.14) | |
| Shares outstanding (diluted) | 8.5 | 7.1 | 3.5 | 40.3 | 33.3 | 13.6 | 1.7 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|